# Graftys

- Location (FDA's records): Aix En Provence, FR
- FDA decisions: 5 (2008–2023): 5 510(k) clearances
- Product codes: MQV (4), LYC (1)
- Predicates its devices cite: 7 (3 its own); citations of its devices by later devices: 4 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Biomatlante: 2 (https://510kreport.com/company/biomatlante)
- Synthes (Usa): 1 (https://510kreport.com/company/synthes-usa)
- Orthovita, Inc.: 1 (https://510kreport.com/company/orthovita)

## Firms that cite its devices most
- Ceramisys, Ltd.: 1 (https://510kreport.com/company/ceramisys)

## Its most-cited devices
- K082498: Graftys HBS (2009), cited by 1
- K093343: Grafty Quickset (2010), cited by 1
- K082286: Bioactys (2009), cited by 1
- K073064: Graftys BCP (2008), cited by 1

## Recent decisions
- K231714: Graftys Quickset (Jul 12, 2023)
- K093343: Grafty Quickset (Apr 22, 2010)
- K082498: Graftys HBS (Feb 25, 2009)
- K082286: Bioactys (Feb 24, 2009)
- K073064: Graftys BCP (Mar 11, 2008)

Source page: https://510kreport.com/company/graftys